4-aminobenzoic acid has been researched along with Chronic Disease in 57 studies
para-Aminobenzoates: Benzoic acids, salts, or esters that contain an amino group attached to carbon number 4 of the benzene ring structure.
4-aminobenzoate : An aromatic amino-acid anion that is the conjugate base of 4-aminobenzoic acid.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a bentiromide test in 25 patients with chronic pancreatitis and 7 normal controls to evaluate pancreatic exocrine function, and compared the test results of patients with their endoscopic retrograde pancreatography(ERP) findings." | 7.70 | Comparative study of bentiromide test and endoscopic retrograde pancreatography in patients with chronic pancreatitis. ( Chung, JB; Kang, JK; Moon, YM; Park, IS; Park, SW; Song, SY, 1998) |
| "Plasma concentrations of pancreatic glucagon, C-peptide, and pancreatic polypeptide were measured during arginine stimulation in 16 patients with chronic pancreatitis, in eight subjects with idiopathic diabetes mellitus, and in seven healthy controls." | 7.67 | Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis. ( Gyr, K; Keller, U; Szöllösy, E; Varga, L, 1984) |
| "Further evaluation of the pancreatic excretion test with 5,5-dimethyl-2,4-oxazolidinedione (dimethadione, DMO) was made in comparison with the pancreozymin-secretin (PS) test on 100 normal subjects, 79 patients with chronic pancreatitis, and 83 patients with nonpancreatic disease." | 7.66 | Clinical evaluation of pancreatic excretion test with dimethadione and oral BT-PABA test in chronic pancreatitis. ( Hayakawa, T; Kameya, A; Katada, N; Kondo, T; Noda, A, 1983) |
| "We performed a bentiromide test in 25 patients with chronic pancreatitis and 7 normal controls to evaluate pancreatic exocrine function, and compared the test results of patients with their endoscopic retrograde pancreatography(ERP) findings." | 3.70 | Comparative study of bentiromide test and endoscopic retrograde pancreatography in patients with chronic pancreatitis. ( Chung, JB; Kang, JK; Moon, YM; Park, IS; Park, SW; Song, SY, 1998) |
| "The BT-PABA/Xylose test was used in 10 healthy cats and 49 cats with chronic diarrhea." | 3.68 | [BT-PABA/xylose test in the cat?]. ( Fischer, S; Kraft, W, 1993) |
| "Plasma concentrations of pancreatic glucagon, C-peptide, and pancreatic polypeptide were measured during arginine stimulation in 16 patients with chronic pancreatitis, in eight subjects with idiopathic diabetes mellitus, and in seven healthy controls." | 3.67 | Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis. ( Gyr, K; Keller, U; Szöllösy, E; Varga, L, 1984) |
| "Further evaluation of the pancreatic excretion test with 5,5-dimethyl-2,4-oxazolidinedione (dimethadione, DMO) was made in comparison with the pancreozymin-secretin (PS) test on 100 normal subjects, 79 patients with chronic pancreatitis, and 83 patients with nonpancreatic disease." | 3.66 | Clinical evaluation of pancreatic excretion test with dimethadione and oral BT-PABA test in chronic pancreatitis. ( Hayakawa, T; Kameya, A; Katada, N; Kondo, T; Noda, A, 1983) |
| "Chronic disseminated intravascular coagulation is a rare complication of aortic dissection." | 1.42 | Effective treatment with para-aminomethylbenzoic acid for chronic disseminated intravascular coagulation associated with aortic dissection. ( Chen, H; Cui, Q; Qin, L; Shen, H; Wang, Z; Wu, T; Yu, Z, 2015) |
| "Patients with acute pancreatitis were studied at various time intervals after the acute attack and compared with controls with abdominal pain that was not pancreatic in origin." | 1.27 | Functional recovery of the exocrine pancreas after acute pancreatitis. ( Kelleher, J; McMahon, MJ; Mitchell, CJ; Playforth, MJ, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (59.65) | 18.7374 |
| 1990's | 13 (22.81) | 18.2507 |
| 2000's | 4 (7.02) | 29.6817 |
| 2010's | 5 (8.77) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Martinez-Zapata, MJ | 2 |
| Vernooij, RW | 2 |
| Simancas-Racines, D | 1 |
| Uriona Tuma, SM | 2 |
| Stein, AT | 2 |
| Moreno Carriles, RMM | 1 |
| Vargas, E | 3 |
| Bonfill Cosp, X | 2 |
| Belczak, SQ | 1 |
| Sincos, IR | 1 |
| Campos, W | 1 |
| Beserra, J | 1 |
| Nering, G | 1 |
| Aun, R | 1 |
| Armani, E | 1 |
| Amari, G | 1 |
| Rizzi, A | 1 |
| De Fanti, R | 1 |
| Ghidini, E | 1 |
| Capaldi, C | 1 |
| Carzaniga, L | 1 |
| Caruso, P | 1 |
| Guala, M | 1 |
| Peretto, I | 1 |
| La Porta, E | 1 |
| Bolzoni, PT | 1 |
| Facchinetti, F | 1 |
| Carnini, C | 1 |
| Moretto, N | 1 |
| Patacchini, R | 1 |
| Bassani, F | 1 |
| Cenacchi, V | 1 |
| Volta, R | 1 |
| Amadei, F | 1 |
| Capacchi, S | 1 |
| Delcanale, M | 1 |
| Puccini, P | 1 |
| Catinella, S | 1 |
| Civelli, M | 1 |
| Villetti, G | 1 |
| Cui, Q | 1 |
| Wu, T | 1 |
| Chen, H | 1 |
| Qin, L | 1 |
| Yu, Z | 1 |
| Shen, H | 1 |
| Wang, Z | 1 |
| Zhang, Y | 1 |
| Liu, L | 1 |
| Liu, YZ | 1 |
| Shen, XL | 1 |
| Wu, TY | 1 |
| Zhang, T | 1 |
| Wang, W | 1 |
| Wang, YX | 1 |
| Jiang, CL | 1 |
| Moreno, RM | 2 |
| Capellà, D | 2 |
| Egesel, T | 1 |
| Unsal, I | 1 |
| Dikmen, G | 1 |
| Bayraktar, Y | 1 |
| Chowdhury, RS | 1 |
| Forsmark, CE | 1 |
| Martinez, MJ | 1 |
| Bonfill, X | 1 |
| Kodama, M | 1 |
| Tanaka, T | 1 |
| Chen, SP | 2 |
| Keller, U | 1 |
| Szöllösy, E | 1 |
| Varga, L | 1 |
| Gyr, K | 3 |
| Noda, A | 1 |
| Hayakawa, T | 2 |
| Kondo, T | 2 |
| Katada, N | 1 |
| Kameya, A | 1 |
| Delchier, JC | 1 |
| Soule, JC | 1 |
| Kay, GH | 2 |
| Tetlow, VA | 2 |
| Braganza, JM | 4 |
| Herman, KJ | 1 |
| Toskes, PP | 1 |
| Cavallini, G | 3 |
| Piubello, W | 2 |
| Brocco, G | 3 |
| Vantini, I | 1 |
| Angelini, G | 1 |
| Benini, L | 1 |
| Chech, G | 1 |
| Marchiaro, G | 1 |
| Dobrilla, G | 2 |
| Bonoldi, C | 2 |
| Lang, C | 1 |
| Tonko, I | 1 |
| Conen, D | 1 |
| Stalder, GA | 1 |
| Mitchell, CJ | 1 |
| Playforth, MJ | 1 |
| Kelleher, J | 1 |
| McMahon, MJ | 1 |
| Lankisch, PG | 1 |
| Ehrhardt-Schmelzer, S | 1 |
| Koop, H | 1 |
| Caspary, WF | 1 |
| Barba, E | 1 |
| Baratta, S | 1 |
| Parolin, P | 1 |
| Scuro, LA | 2 |
| Manabe, T | 1 |
| Yokota, T | 1 |
| Tobe, T | 1 |
| Kimura, T | 1 |
| Wakasugi, H | 1 |
| Ibayashi, H | 1 |
| Chaloner, C | 2 |
| Segal, I | 1 |
| Hassan, H | 1 |
| McIntosh, J | 1 |
| Gut, A | 1 |
| Rahme, M | 1 |
| Semba, D | 1 |
| Ishihara, Y | 1 |
| Morioka, Y | 1 |
| Fischer, S | 1 |
| Kraft, W | 1 |
| Furuya, KN | 1 |
| Durie, PR | 1 |
| Roberts, EA | 1 |
| Soldin, SJ | 1 |
| Verjee, Z | 1 |
| Yung-Jato, L | 1 |
| Giesbrecht, E | 1 |
| Ellis, L | 1 |
| Małecka-Panas, E | 1 |
| Juszyński, A | 1 |
| Chrzastek, J | 1 |
| Krysiak, G | 1 |
| Torzecka, W | 1 |
| Oyama, H | 1 |
| Watanabe, S | 1 |
| Kataoka, K | 2 |
| Yamane, Y | 1 |
| Kato, M | 2 |
| Kashima, K | 2 |
| Kitagawa, M | 1 |
| Naruse, S | 1 |
| Ishiguro, H | 1 |
| Nakae, Y | 1 |
| Chung, JB | 1 |
| Park, SW | 1 |
| Song, SY | 1 |
| Moon, YM | 1 |
| Kang, JK | 1 |
| Park, IS | 1 |
| Ochi, K | 1 |
| Mizushima, T | 1 |
| Harada, H | 1 |
| Matsumoto, S | 1 |
| Matsumura, N | 1 |
| Seno, T | 1 |
| Hosoda, M | 1 |
| Yasuda, H | 1 |
| Sakagami, J | 1 |
| Eddes, EH | 1 |
| Verkijk, M | 1 |
| Gielkens, HA | 1 |
| Biemond, I | 1 |
| Bemelman, W | 1 |
| Lamers, CB | 1 |
| Masclee, AA | 1 |
| Arvanitakis, C | 1 |
| Greenberger, NJ | 1 |
| Kato, K | 1 |
| Izumiyama, S | 1 |
| Sakakura, M | 1 |
| Hirayama, A | 1 |
| Ishii, K | 1 |
| Imamura, K | 1 |
| Nakamura, T | 1 |
| Miyazawa, T | 1 |
| Abe, Y | 1 |
| Kobayashi, M | 1 |
| Takebe, K | 1 |
| Toyota, T | 1 |
| Thienhaus, R | 1 |
| Niederau, C | 2 |
| Gagee, P | 1 |
| Pemberton, P | 1 |
| Lobley, R | 1 |
| Snehalatha, C | 1 |
| Mohan, V | 1 |
| Turecka-Kulesza, E | 1 |
| Długosz, J | 1 |
| Gabryelewicz, A | 1 |
| Gilinsky, NH | 2 |
| Chen, WL | 1 |
| Morishita, R | 1 |
| Eguchi, T | 1 |
| Kawai, T | 1 |
| Sakai, M | 1 |
| Tateishi, H | 1 |
| Uchino, H | 1 |
| De Anna, D | 1 |
| Mari, F | 1 |
| Intini, S | 1 |
| Gasbarro, V | 1 |
| Sortini, A | 1 |
| Pozza, E | 1 |
| Marzola, R | 1 |
| Taddeo, U | 1 |
| Bresadola, F | 1 |
| Donini, I | 1 |
| Barba, A | 1 |
| Schena, D | 1 |
| Chieregato, GC | 1 |
| Riela, A | 1 |
| Liu, GJ | 1 |
| Zhou, ZC | 1 |
| Meyer, B | 1 |
| Bátovský, M | 1 |
| Vavrecka, A | 1 |
| Michelecková, D | 1 |
| Brimichová, G | 1 |
| Mee, AS | 1 |
| Girdwood, AH | 1 |
| Walker, E | 1 |
| Kottler, RE | 1 |
| Marks, IN | 1 |
| Berg, JD | 1 |
| Chesner, I | 1 |
| Lawson, N | 1 |
| Myoen, R | 1 |
| Takebe, T | 1 |
| Ohyama, K | 1 |
| Takeda, Y | 1 |
| Amatsu, T | 1 |
| Tada, H | 1 |
| Tukiyama, J | 1 |
| Itabashi, T | 1 |
| Li, W | 1 |
| Ohura, M | 1 |
| Fujita, T | 1 |
| Majima, K | 1 |
| Ohshiba, S | 1 |
| Martínez Martínez, LM | 1 |
| González Villarón, L | 1 |
| Sánchez Sánchez, R | 1 |
| Rodrigo Sáez, L | 1 |
| de Castro del Pozo, S | 1 |
| Bornschein, W | 1 |
| Rageh, W | 1 |
| Klugmann, HJ | 1 |
| Schiedewitz, W | 1 |
| Pohl, A | 1 |
| Grendell, JH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A 17 Week, Randomised, Double-blind, Placebo Controlled Cross-over Trial to Evaluate the Efficacy of Antistax® Film Coated Tablets (Extr. Vitis Vinifera Siccum), 360 mg/Day p.o. in Improving Microcirculation of the Skin in the Leg of Male and Female Patie[NCT02191163] | Phase 2 | 71 participants (Actual) | Interventional | 2002-04-30 | Completed | ||
| Randomized, Double-blind Multicenter Clinical Trial Comparing the Efficacy of Calcium Dobesilate With Placebo in the Treatment of Ulcer Secondaries to Chronic Venous Disease[NCT00979836] | Phase 3 | 230 participants (Anticipated) | Interventional | 2008-04-30 | Suspended (stopped due to The financial support was withdrawn.) | ||
| Evaluation of Efficacy and Safety of the Fixed-dose Combination of Coumarin and Troxerutin (Venalot®) Versus Placebo in the Symptomatic Treatment of Chronic Venous Insufficiency - VENACT[NCT01848210] | Phase 4 | 829 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
| The Ability of Antistax® to Improve Chronic Venous Insufficiency (CVI) I and II in Male and Female Patients: a Dose Response Study[NCT02191280] | Phase 2 | 260 participants (Actual) | Interventional | 1998-04-30 | Completed | ||
| A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial to Evaluate Efficacy and Tolerability of Antistax® Film Coated Tablets, 360 mg/Day Orally, in Male and Female Patients Suffering From Chronic Venous Insufficiency[NCT02191254] | Phase 3 | 245 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| Assessment of the Efficacy and Safety of Diosmin 600mg on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs: a Multicentric, Randomised, Double-blind, Placebo-controlled Trial in Parallel Groups[NCT01532882] | Phase 3 | 378 participants (Actual) | Interventional | 2012-01-31 | Completed | ||
| Study of Antiinflammatory Effects of Detralex (Daflon) in Patients With Chronic Venous Disease[NCT01654016] | Phase 4 | 84 participants (Actual) | Interventional | 2012-08-31 | Completed | ||
| Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy of µSmin® Plus (Dietary Supplement) in Chronic Venous Insufficiency Symptoms Relief[NCT04101201] | 73 participants (Actual) | Interventional | 2019-11-15 | Completed | |||
| The MUFFIN-PTS Trial: Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome[NCT03833024] | Phase 3 | 88 participants (Actual) | Interventional | 2022-02-04 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Local Complaint Severity will be assessed using the Severity Score of Local Complaints that comprises 8 items: 1=tired legs, 2=heavy legs, 3= feeling of tension, 4=feeling of swelling, 5=aching legs, 6=tingling, 7=itching, 8=burning of soles of the feet.~Each item is classified with a Likert-type scale of 5 levels, where 0=absent, 1=low, 2=medium, 3=high, 4=very high.~A total score is calculated from the sum of the scores of all the 8 items and ranges from 0 (complaints absent) to 32 (very high severity)." (NCT01848210)
Timeframe: Baseline and Week 16
| Intervention | score on a scale (Mean) |
|---|---|
| Coumarin + Troxerutin | 10.83 |
| Placebo | 10.45 |
Change in the partial volume of legs will be measured using a water plethysmometer. The volume of water (at 34 ± 0.2 °C) displaced after limb immersion is collected in an empty plastic Beaker which has been previously weighed (scale tare). The equilibrium/stability will be estimated using the absolute difference between measures of volume obtained at the Week 16 visit and Baseline to determine the reduction in edema. (NCT01848210)
Timeframe: Baseline and Week 16
| Intervention | milliliters (mL) (Mean) |
|---|---|
| Coumarin + Troxerutin | 1.13 |
| Placebo | 5.78 |
Adverse events are any unwanted medical occurrences in an individual taking part in a clinical study who is receiving a pharmaceutical product. The adverse event does not have necessarily a causal relationship with the treatment. In this definition, any adverse or unwanted signals and symptoms, or findings that appear from the start or that deteriorate during the clinical study are also included, i.e. any intercurrent diseases (recently diagnosed concomitant diseases or symptoms), accidents and clinically relevant changes in clinical laboratory values. (NCT01848210)
Timeframe: Baseline to Week 16
| Intervention | participants (Number) |
|---|---|
| Coumarin + Troxerutin | 131 |
| Placebo | 120 |
The investigator recorded their impression of the overall clinical picture at the end of the treatment period (Week 16), taking into account the clinical picture compared with the Baseline visit. Data is reported for the percentage of participants in each of the following assessment categories: worsening, unchanged, discreet improvement or accentuated improvement. (NCT01848210)
Timeframe: Baseline and Week 16
| Intervention | percentage of participants (Number) | |||
|---|---|---|---|---|
| Worsening | Unchanged | Discreet improvement | Accentuated improvement | |
| Coumarin + Troxerutin | 0.6 | 11.2 | 25.3 | 62.9 |
| Placebo | 0.8 | 14.3 | 24.4 | 60.4 |
8 reviews available for 4-aminobenzoic acid and Chronic Disease
| Article | Year |
|---|---|
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Angioedemas, Hereditary; Calcium Dobesilate; Centella; Chronic Disease; Diosmin | 2020 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Calcium Dobesilate; Centella; Chronic Disease; Diosmin; Edema; Hematologic Agen | 2016 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Calcium Dobesilate; Centella; Chronic Disease; Diosmin; Edema; Hematologic Agen | 2016 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Calcium Dobesilate; Centella; Chronic Disease; Diosmin; Edema; Hematologic Agen | 2016 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Calcium Dobesilate; Centella; Chronic Disease; Diosmin; Edema; Hematologic Agen | 2016 |
Review article: Pancreatic function testing.
Topics: 4-Aminobenzoic Acid; Breath Tests; Chronic Disease; Endopeptidases; Enzymes; Fats; Feces; Fluorescei | 2003 |
Phlebotonics for venous insufficiency.
Topics: 4-Aminobenzoic Acid; Calcium Dobesilate; Centella; Chronic Disease; Diosmin; Hematologic Agents; Hum | 2005 |
[PFD test (bentiromide test, BT-PABA test)].
Topics: 4-Aminobenzoic Acid; Chronic Disease; Humans; Pancreatic Function Tests; Pancreatitis; para-Aminoben | 1997 |
Chronic pancreatitis: functional testing.
Topics: 4-Aminobenzoic Acid; Absorption; Cholecystokinin; Chronic Disease; Digestion; Humans; Islets of Lang | 1998 |
Pancreatic function testing. Methods to identify exocrine insufficiency.
Topics: 4-Aminobenzoic Acid; Chronic Disease; Feces; Humans; Pancreas; Pancreatic Function Tests; Pancreatit | 1989 |
Diagnosis of chronic pancreatitis.
Topics: 4-Aminobenzoic Acid; Biopsy, Needle; Child; Chronic Disease; Diagnosis, Differential; Duodenum; Fluo | 1985 |
6 trials available for 4-aminobenzoic acid and Chronic Disease
| Article | Year |
|---|---|
Veno-active drugs for chronic venous disease: A randomized, double-blind, placebo-controlled parallel-design trial.
Topics: Biomechanical Phenomena; Brazil; Cardiovascular Agents; Chronic Disease; Coumarins; Diosmin; Double- | 2014 |
The assessment of pancreatic exocrine function by bentiromide test in patients with chronic portal vein thrombosis.
Topics: 4-Aminobenzoic Acid; Adult; Atrophy; Cholangiopancreatography, Endoscopic Retrograde; Chronic Diseas | 2002 |
Clinical study of exocrine pancreatic function test by oral administration by N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Cholecystokinin; Chronic Disease; Clinical Trials as Topic; Hum | 1981 |
Diagnosis of chronic pancreatitis using noninvasive tests of exocrine pancreatic function--comparison to duodenal intubation tests.
Topics: 4-Aminobenzoic Acid; Chronic Disease; Chymotrypsin; Duodenum; Feces; Female; Humans; Intubation, Gas | 1997 |
Evaluating exocrine function tests for diagnosing chronic pancreatitis.
Topics: 4-Aminobenzoic Acid; Amylases; Cholangiopancreatography, Endoscopic Retrograde; Chronic Disease; Chy | 1997 |
[Exocrine pancreatic function test by N-benzoyl-L-tyrosyl-p-aminobenzoic acid (author's transl)].
Topics: 4-Aminobenzoic Acid; Adolescent; Adult; Aminobenzoates; Chronic Disease; Humans; Middle Aged; Pancre | 1979 |
43 other studies available for 4-aminobenzoic acid and Chronic Disease
| Article | Year |
|---|---|
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Benzoates; Cel | 2014 |
Effective treatment with para-aminomethylbenzoic acid for chronic disseminated intravascular coagulation associated with aortic dissection.
Topics: Antifibrinolytic Agents; Aortic Diseases; Aortic Dissection; Aortography; Blood Vessel Prosthesis Im | 2015 |
NLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Carrier Proteins; Caspase 1 | 2015 |
Residual function of exocrine pancreas after operation for chronic pancreatitis by N-benzoyl-L-tyrosyl-p-aminobenzoic acid test (NBT-PABA test).
Topics: 4-Aminobenzoic Acid; Adult; Aminobenzoates; Chronic Disease; Chymotrypsin; Humans; Middle Aged; Panc | 1984 |
[Serum pancreatic polypeptide measurement in the diagnosis of chronic pancreatitis].
Topics: 4-Aminobenzoic Acid; Adult; Aged; Cholangiopancreatography, Endoscopic Retrograde; Chronic Disease; | 1984 |
Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Arginine; Blood Glucose; C-Peptide; Chronic Disease; Diabetes M | 1984 |
Clinical evaluation of pancreatic excretion test with dimethadione and oral BT-PABA test in chronic pancreatitis.
Topics: 4-Aminobenzoic Acid; Adult; Aminobenzoates; Chronic Disease; Dimethadione; Female; Humans; Male; Mid | 1983 |
BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity.
Topics: 4-Aminobenzoic Acid; Adult; Aged; Aminobenzoates; Celiac Disease; Chronic Disease; Evaluation Studie | 1983 |
Relationship between PABA and Lundh tests: lack of influence of duodenal pH in vivo.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Chronic Disease; Chymotrypsin; Duodenum; Humans; Hydrogen-Ion C | 1983 |
Observations on the BT PABA/14C-PABA tubeless test of pancreatic function.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Carbon Radioisotopes; Chronic Disease; Humans; Hydrogen-Ion Con | 1983 |
Bentiromide as a test of exocrine pancreatic function in adult patients with pancreatic exocrine insufficiency. Determination of appropriate dose and urinary collection interval.
Topics: 4-Aminobenzoic Acid; Adolescent; Adult; Aged; Aminobenzoates; Chronic Disease; Diarrhea; Exocrine Pa | 1983 |
Reliability of the Bz-Ty-PABA and the pancreolauryl test in the assessment of exocrine pancreatic function.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Ceruletide; Chronic Disease; Exocrine Pancreatic Insufficiency; | 1983 |
Value of serum PABA as a pancreatic function test.
Topics: 4-Aminobenzoic Acid; Acute Disease; Adult; Aged; Aminobenzoates; Chronic Disease; Female; Gastrointe | 1984 |
Functional recovery of the exocrine pancreas after acute pancreatitis.
Topics: 4-Aminobenzoic Acid; Acute Disease; Adult; Aged; Chronic Disease; Female; Humans; Male; Middle Aged; | 1983 |
[The NBT-PABA test in the diagnosis of exocrine pancreatic insufficiency (author's transl)].
Topics: 4-Aminobenzoic Acid; Adolescent; Adult; Aged; Aminobenzoates; Cholecystokinin; Chronic Disease; Exoc | 1980 |
Urinary PABA recovery after oral N-benzoyl-L-tyrosyl-PABA administration combined with various exocrine pancreatic stimulants.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Ceruletide; Chronic Disease; Humans; Infusions, Parenteral; Inj | 1980 |
Evaluation of postoperative exocrine pancreatic function using chymotrypsin labile peptide.
Topics: 4-Aminobenzoic Acid; Administration, Oral; Aminobenzoates; Chronic Disease; Gastrectomy; Humans; Pan | 1982 |
A preliminary report on urinary BT-PABA/PAS excretion index, serum pancreatic isoamylase and faecal chymotrypsin tests of pancreatic dysfunction in Sowetan Africans.
Topics: 4-Aminobenzoic Acid; Adult; Aminosalicylic Acid; Biomarkers; Black People; Chronic Disease; Chymotry | 1995 |
[Reexamination of BT-PABA test (PFD)--on the substrate specificity for pancreatic chymotrypsin in vivo].
Topics: 4-Aminobenzoic Acid; Animals; Chronic Disease; Dogs; Humans; Pancreatectomy; Pancreatic Function Tes | 1994 |
[BT-PABA/xylose test in the cat?].
Topics: 4-Aminobenzoic Acid; Animals; Cat Diseases; Cats; Chronic Disease; Diarrhea; Pancreatic Function Tes | 1993 |
Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function.
Topics: 4-Aminobenzoic Acid; Acute Disease; Adolescent; Aminohippuric Acids; Child; Child, Preschool; Chroni | 1995 |
[Comparison of three indirect pancreatic function tests in severe chronic pancreatitis--personal observations].
Topics: 4-Aminobenzoic Acid; Adult; Aged; Chronic Disease; Chymotrypsin; Feces; Female; Fluoresceins; Humans | 1995 |
Comparative study of bentiromide test and endoscopic retrograde pancreatography in patients with chronic pancreatitis.
Topics: 4-Aminobenzoic Acid; Adult; Aged; Bicarbonates; Chronic Disease; Female; Humans; Male; Middle Aged; | 1998 |
Assessment of exocrine pancreatic dysfunction in chronic pancreatitis.
Topics: 4-Aminobenzoic Acid; Chronic Disease; Chymotrypsin; Diagnosis, Differential; Feces; Humans; Pancreas | 1999 |
Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.
Topics: 4-Aminobenzoic Acid; Adult; Aged; Bombesin; Chronic Disease; Eating; Female; Humans; Male; Middle Ag | 2001 |
Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function.
Topics: 4-Aminobenzoic Acid; Adenocarcinoma; Adult; Aminobenzoates; Chronic Disease; Dipeptides; Female; Hum | 1976 |
Study on the exocrine pancreatic function by the oral administration of N-benzoyl-L-tyrosyl-para-aminobenzoic acid.
Topics: 4-Aminobenzoic Acid; Administration, Oral; Adolescent; Adult; Aged; Aminobenzoates; Chronic Disease; | 1977 |
Oral administration of chymotrypsin labile peptide for a new test of exocrine pancreatic function (PET) in comparison and pancreozymin-secretin test.
Topics: 4-Aminobenzoic Acid; Adult; Aged; Aminobenzoates; Cholecystokinin; Chronic Disease; Female; Humans; | 1978 |
The BT-PABA/PAS test in tropical diabetes.
Topics: 4-Aminobenzoic Acid; Aminosalicylic Acid; Chronic Disease; Chymotrypsin; Diabetes Complications; Dia | 1992 |
[Diagnostic value of the NBT-PABA test in chronic pancreatitis].
Topics: 4-Aminobenzoic Acid; Adult; Chronic Disease; False Negative Reactions; Humans; Middle Aged; Pancreat | 1990 |
Clinical usefulness of dual-label Schilling test for pancreatic exocrine function.
Topics: 4-Aminobenzoic Acid; Adult; Animals; Bicarbonates; Cholangiopancreatography, Endoscopic Retrograde; | 1989 |
[Effects of therapy with aminaftone on chronic venous and lymphatic stasis].
Topics: 4-Aminobenzoic Acid; Adult; Aged; Aminobenzoates; Chronic Disease; Drug Evaluation; Female; Humans; | 1989 |
Exocrine pancreatic function in chronic urticaria patients is normal.
Topics: 4-Aminobenzoic Acid; Chronic Disease; Chymotrypsin; Feces; Female; Fluorescein; Fluoresceins; Humans | 1988 |
[Clinical significance of plasma PABA determination as a pancreatic exocrine function test].
Topics: 4-Aminobenzoic Acid; Adolescent; Adult; Aminobenzoates; Chronic Disease; Female; Humans; Male; Middl | 1986 |
[Significance of the oral NBT-PABA test for the diagnosis of chronic pancreatitis].
Topics: 4-Aminobenzoic Acid; Administration, Oral; Aminobenzoates; Chronic Disease; Exocrine Pancreatic Insu | 1987 |
[Personal experience in studying the exocrine function of the pancreas using Spofagnost].
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Chronic Disease; Humans; Pancreatic Function Tests; Pancreatiti | 1985 |
Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.
Topics: 4-Aminobenzoic Acid; Adult; Alcoholism; Calcinosis; Cholangiopancreatography, Endoscopic Retrograde; | 1985 |
Practical assessment of the NBT-PABA pancreatic function test using high performance liquid chromatography determination of p-aminobenzoic acid in urine.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Chromatography, High Pressure Liquid; Chronic Disease; Humans; | 1985 |
The usefulness of serum PABA measurement after BT-PABA administration in the diagnosis of chronic pancreatitis.
Topics: 4-Aminobenzoic Acid; Adult; Aminobenzoates; Bicarbonates; Ceruletide; Chronic Disease; Chymotrypsin; | 1985 |
[Value of the BT-PABA test with serum PABA as a pancreatic function test].
Topics: 4-Aminobenzoic Acid; Adolescent; Adult; Aged; Aminobenzoates; Chronic Disease; Female; Humans; Male; | 1985 |
[Functional examination of the pancreas with indirect methods (the NBT-PABA test and pancreolauryl test) in patients with chronic pancreatic diseases].
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Chronic Disease; Female; Fluoresceins; Humans; Male; Middle Age | 1985 |
[Improvement in the specificity of the PABA test (PFT) by combined PABA peptide/D-xylose administration and serum kinetic measurement?].
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Chronic Disease; Exocrine Pancreatic Insufficiency; Female; Hum | 1985 |
[Modified ALTAB test in the diagnosis of exocrine pancreatic insufficiency].
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Chronic Disease; Exocrine Pancreatic Insufficiency; Humans; Pan | 1985 |